Chemed Corporation (NYSE: CHE) reported Q3 EPS of $3.07, $0.27 better than the analyst estimate of $2.80. Revenue for the quarter came in at $444 million versus the consensus estimate of $445.16 million.

GUIDANCE:

Chemed Corporation sees Q4 2018 EPS of $11.80-$11.90, versus the consensus of $11.47.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.